Literature DB >> 15451670

Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.

T Scott Reid1, Kimberly L Terry, Patrick J Casey, Lorena S Beese.   

Abstract

Post-translational modifications are essential for the proper function of many proteins in the cell. The attachment of an isoprenoid lipid (a process termed prenylation) by protein farnesyltransferase (FTase) or geranylgeranyltransferase type I (GGTase-I) is essential for the function of many signal transduction proteins involved in growth, differentiation, and oncogenesis. FTase and GGTase-I (also called the CaaX prenyltransferases) recognize protein substrates with a C-terminal tetrapeptide recognition motif called the Ca1a2X box. These enzymes possess distinct but overlapping protein substrate specificity that is determined primarily by the sequence identity of the Ca1a2X motif. To determine how the identity of the Ca1a2X motif residues and sequence upstream of this motif affect substrate binding, we have solved crystal structures of FTase and GGTase-I complexed with a total of eight cognate and cross-reactive substrate peptides, including those derived from the C termini of the oncoproteins K-Ras4B, H-Ras and TC21. These structures suggest that all peptide substrates adopt a common binding mode in the FTase and GGTase-I active site. Unexpectedly, while the X residue of the Ca1a2X motif binds in the same location for all GGTase-I substrates, the X residue of FTase substrates can bind in one of two different sites. Together, these structures outline a series of rules that govern substrate peptide selectivity; these rules were utilized to classify known protein substrates of CaaX prenyltransferases and to generate a list of hypothetical substrates within the human genome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451670     DOI: 10.1016/j.jmb.2004.08.056

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  100 in total

1.  Differential effects of prenylation and s-acylation on type I and II ROPS membrane interaction and function.

Authors:  Nadav Sorek; Orit Gutman; Einat Bar; Mohamad Abu-Abied; Xuehui Feng; Mark P Running; Efraim Lewinsohn; Naomi Ori; Einat Sadot; Yoav I Henis; Shaul Yalovsky
Journal:  Plant Physiol       Date:  2010-12-07       Impact factor: 8.340

Review 2.  Therapeutic intervention based on protein prenylation and associated modifications.

Authors:  Michael H Gelb; Lucas Brunsveld; Christine A Hrycyna; Susan Michaelis; Fuyuhiko Tamanoi; Wesley C Van Voorhis; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2006-10       Impact factor: 15.040

3.  Transition state analysis of model and enzymatic prenylation reactions.

Authors:  Stepan Lenevich; Juhua Xu; Ayako Hosokawa; Christopher J Cramer; Mark D Distefano
Journal:  J Am Chem Soc       Date:  2007-04-17       Impact factor: 15.419

4.  Synthesis and evaluation of 3- and 7-substituted geranylgeranyl pyrophosphate analogs.

Authors:  Michelle Maynor; Sarah A Scott; Emily L Rickert; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2008-02-12       Impact factor: 2.823

Review 5.  Geranylgeranyltransferase I as a target for anti-cancer drugs.

Authors:  Mark R Philips; Adrienne D Cox
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

7.  Protein geranylgeranyltransferase-I of Trypanosoma cruzi.

Authors:  Kohei Yokoyama; John R Gillespie; Wesley C Van Voorhis; Frederick S Buckner; Michael H Gelb
Journal:  Mol Biochem Parasitol       Date:  2007-10-02       Impact factor: 1.759

8.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates.

Authors:  Amanda J Krzysiak; Animesh V Aditya; James L Hougland; Carol A Fierke; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2009-11-12       Impact factor: 2.823

10.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.